ID: ALA4798511

Max Phase: Preclinical

Molecular Formula: C26H24BrClN2

Molecular Weight: 399.94

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Clc1ccc2c(N3CCCC3)cc[n+](Cc3ccc(-c4ccccc4)cc3)c2c1.[Br-]

Standard InChI:  InChI=1S/C26H24ClN2.BrH/c27-23-12-13-24-25(28-15-4-5-16-28)14-17-29(26(24)18-23)19-20-8-10-22(11-9-20)21-6-2-1-3-7-21;/h1-3,6-14,17-18H,4-5,15-16,19H2;1H/q+1;/p-1

Standard InChI Key:  FQGXPCHSLFSSGS-UHFFFAOYSA-M

Associated Targets(Human)

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HT-29 80576 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

RS4-11 1012 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CCRF-CEM 65223 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Choline kinase alpha 330 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 399.94Molecular Weight (Monoisotopic): 399.1623AlogP: 6.10#Rotatable Bonds: 4
Polar Surface Area: 7.12Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 2.32CX LogD: 2.32
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.38Np Likeness Score: -0.63

References

1. Serrán-Aguilera L,Mariotto E,Rubbini G,Castro Navas FF,Marco C,Carrasco-Jiménez MP,Ballarotto M,Macchiarulo A,Hurtado-Guerrero R,Viola G,Lopez-Cara LC.  (2020)  Synthesis, biological evaluation, in silico modeling and crystallization of novel small monocationic molecules with potent antiproliferative activity by dual mechanism.,  207  [PMID:32977218] [10.1016/j.ejmech.2020.112797]

Source